Faslodex

Type: Product

Name: Faslodex

First reported Feb 15 2013 - Updated Feb 15 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Faslodex, fulvestrant, Revision: 11, Authorised

[Published Pending EC decisions and European Public Assess ... - Feb 15 2013]

Quotes

...Rukazenkov said despite advances in treatment and detection, breast cancer remains the primary cause of cancer death in women around the world. "The FALCON trial is part of AstraZeneca's commitment to the continued study and evaluation of treatment options for metastatic breast cancer, and developing and optimizing breast cancer therapies for all patient groups" Rukazenkov added...

AstraZeneca commences FALCON breast cancer trial [Published Pharmaceutical Business Review - Oct 31 2012]

More Content

sort by: Date \| Relevance
Postmenopausal Hormone Receptor–Positive Advanc... [Published Cancernetwork.com - Jun 18 2013]
Breast cancer [Published MayoClinic.com - May 23 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Feb 15 2013]
DELÅRSRAPPORT FÖR FJÄRDE KVARTALET OCH JANUARI ... [Published GlobeNewswire: Acquisitions News - Jan 31 2013]
AstraZeneca commences FALCON breast cancer trial [Published Pharmaceutical Business Review - Oct 31 2012]
AstraZeneca commences FALCON breast cancer trial [Published BioPortfolio - Oct 31 2012]
AstraZeneca Begins a New Global Study of FASLOD... [Published BioPortfolio - Oct 29 2012]